financetom
Business
financetom
/
Business
/
Hertz Misses On Revenue, Profit As Fleet Shrinks, Costs Weigh
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hertz Misses On Revenue, Profit As Fleet Shrinks, Costs Weigh
Feb 13, 2025 6:46 AM

Shares of Hertz Global Holdings, Inc ( HTZ ) are trading lower in premarket on Thursday.

The company reported a fourth-quarter FY24 sales decline of 6.6% year-on-year to $2.04 billion, missing the analyst consensus estimate of $2.12 billion.

Average rentable vehicles decreased by 6% to 497,875, with 79% vehicle utilization.

Total revenue per day (RPD) declined 2% to $57.10. Americas RAC segment revenue decreased by 8% whereas the International RAC segment slipped 2%.

Also Read: Burger King Parent Restaurant Brands Q4: Earnings Beat, 26% Sales Jump, Popeyes Comps Dip And More

Selling, general and administrative expenses decreased 8.9% to $225 million.

As of the end of December, Hertz had $592 million in cash and equivalents, and its operating cash flow for the quarter totaled $414 million.

Adjusted corporate EBITDA for the quarter was $(357) million, with an adjusted corporate EBITDA margin of (18)%.

Adjusted EPS of $(1.18) missed the consensus estimate of $(0.71).

"Our focus in 2024 was stabilizing the business and implementing fundamental changes to transform our company," said CEO Gil West. "With our new leadership team and organizational structure in place, we are well positioned to execute our strategy with rigor and at pace."

Price Action: HTZ shares are trading lower by 12.0% at $3.75 in premarket at last check Thursday.

Read Next:

‘Racism Has No Place in Missouri’: State Attorney General Sues Starbucks Over Hiring Policies

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna Receives $176 Million Award to Boost Development of mRNA-Based Pandemic Flu Vaccine
Moderna Receives $176 Million Award to Boost Development of mRNA-Based Pandemic Flu Vaccine
Jul 2, 2024
08:12 AM EDT, 07/02/2024 (MT Newswires) -- Moderna ( MRNA ) said Tuesday it has been awarded a project worth $176 million through the Rapid Response Partnership Vehicle to boost development of mRNA-based pandemic influenza vaccines. The biotech company said the project award will support late-stage development to create an mRNA-based pre-pandemic vaccine against the H5 influenza virus, which causes...
American Airlines enters provisional deal for 100 hydrogen-electric engines
American Airlines enters provisional deal for 100 hydrogen-electric engines
Jul 2, 2024
July 2 (Reuters) - American Airlines ( AAL ) said on Tuesday it had entered into a provisional agreement to buy 100 hydrogen-electric engines from engine maker ZeroAvia. ...
ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets
ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets
Jul 2, 2024
08:09 AM EDT, 07/02/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Tuesday that the US Food and Drug Administration has approved its abbreviated new drug application for its Naproxen delayed-release tablets, a generic version of EC-Naprosyn. Naproxen is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation. US annual sales for Naproxen delayed-release tablets total about $36.7...
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe
Jul 2, 2024
July 2 (Reuters) - Viatris ( VTRS ) said on Tuesday that its unit Mylan is no longer a subject of the U.S. Department of Justice's antitrust investigation into alleged price fixing in the generic drug industry. Viatris ( VTRS ) was formed through the merger of Mylan and Pfizer's Upjohn in 2020. Mylan and several major drugmakers such as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved